Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paper

Por Herzog, Thomas J., Armstrong, Deborah K., Brady, Mark F., Coleman, Robert L., Einstein, Mark H., Monk, Bradley J., Mannel, Robert S., Thigpen, J. Tate, Umpierre, Sharee A., Villella, Jeannine A., Alvarez, Ronald D.
Publicado no Gynecol Oncol (2013)

Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients

Por Berinstein, Neil L, Karkada, Mohan, Oza, Amit M, Odunsi, Kunle, Villella, Jeannine A, Nemunaitis, John J, Morse, Michael A, Pejovic, Tanja, Bentley, James, Buyse, Marc, Nigam, Rita, Weir, Genevieve M, MacDonald, Lisa D, Quinton, Tara, Rajagopalan, Rajkannan, Sharp, Kendall, Penwell, Andrea, Sammatur, Leeladhar, Burzykowski, Tomasz, Stanford, Marianne M, Mansour, Marc
Publicado no Oncoimmunology (2015)